Nitric oxide and liver diseases: Deleterious or beneficial?;Monoxyde d'azote et maladies du foie: Role deletere ou hepatoprotecteur?

Gastroenterologie Clinique et Biologique

Volumn 23, Issue 8-9, 1999, Pages 892-902

  Vuillemin, Eric ^a,b   Veal, Nary ^a   Croquet, Vincent ^a,b   Pilette, Christophe ^a,b   Douay, Olivier ^b   Calés, Paul ^a,b  

^a UNIVERSITÉ D'ANGERS   (France)

^b ANGERS UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; OXYGEN RADICAL;

APOPTOSIS; CELL PROTECTION; ENDOTOXEMIA; HEMODYNAMICS; LIVER BLOOD FLOW; LIVER CIRRHOSIS; LIVER DISEASE; LIVER FIBROSIS; LIVER METABOLISM; REPERFUSION INJURY; REVIEW;

ANIMALS; ENDOTOXEMIA; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER DISEASES; NITRIC OXIDE; REACTIVE OXYGEN SPECIES; REPERFUSION INJURY;

EID: 0032852392     PISSN: 03998320     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (107)

1. Palmer RM, Ferrige AG, Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987;327:524-6.
2. Moncada S, Higgs EA. The L-arginine nitric oxide pathway. N Engl J Med 1993;329:2002-12.
3. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 1989;3:2007-18.
4. Choi DW. Nitric oxide: foe or friend to the injured brain ? Proc Natl Acad Sci USA 1993;90:9741-3.
5. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994;269:13725-8.
6. Morris SM, Billiar TR. New insights into the regulation of inductible nitric oxide synthesis. Am J Physiol 1994;266:E829-39.
7. Laskin DL, Rodriguez Del Valle M, Heck DE, Hwang SM, Ohnishi ST, Durham SK, et al. Hepatic nitric oxide production following acute endotoxemia in rats is mediated by increased inducible nitric oxide synthase gene expression. Hepatology 1995;22:223-34.
8. Schroeder RA, Gu JS, Kuo PC. Interleukin Ibeta;-stimulated production of nitric oxide in rat hepatocytes is mediated through endogenous synthesis of interferon gamma. Hepatology 1998;27: 7119.
9. Yao SK, Ober JC, Krishnaswami A, Ferguson JJ, Anderson HV, Golino P, et al. Endogenous nitric oxide protects against platelet aggregation and cyclic flow variations in stenosed and endothelium-injured arteries. Circulation 1992;86:1302-9.
10. Clancy RM, Leszczynska-Piziak J, Abramson SB. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil Superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest 1992;90:1116-21.
11. Kubes P. Ischemia-reperfusion in feline small intestine: a role for nitric oxide. Am J Physiol 1993;264:G143-9.
12. Stuehr DJ, Marietta MA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Escherichia coli lipopolysaccharide. Proc Natl Acad Sci USA 1985;82: 7738-42.
13. Munoz-Fernandez MA, Fernandez MA, Fresno M. Synergism between tumor necrosis factor-alpha and interferon-gamma on macrophage activation for the killing of intracellular Trypanosoma cruzi through a nitric oxide-dependent mechanism. Eur J Immunol 1992;22:301-7.
14. Sherman MP, Loro ML, Wong VS, Taskin DP. Cytokine and Pneumocystis carinii-induced L-arginine oxidation by murine and human pulmonary alveolar macrophages. J Protozool 1991;38: S234-6.
15. Moncada S, Palmer RMJ, Higgs EA. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev 1991;43: 109-42.
16. Hibbs JB Jr, Taintor RR, Vavrin Z, Rachlin EM. Nitric oxide: a cytoloxic activated macrophage effector molecule. Biochem Biophys Res Commun 1988;157:87-94.
17. Albina JE, Cui S, Mateo RB, Reichner JS. Nitric oxide-mediated apoptosis in murine peritoneal macrophage. J Immunol 1993;150: 5080-5.
18. Pryor WA, Squadrito GL. The chemistry of peroxynitrite: a product from the reaction of nitric oxide with superoxide. Am J Physiol 1995;268:L699-722.
19. Harbrecht BG, Billiar TR. The role of nitric oxide in Kupffer cell-hepatocyte interactions. Shock 1995;3:79-87.
20. Rockey D. The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin and nitric oxide. Hepatology 1997;25:1-5.
21. Rockey DC, Chung JJ. Reduced nitric oxide production by endothelial cells in cirrhotic rat liver: endothelial dysfunction in portal hypertension. Gastroenterology 1998;114:344-51.
22. West MA, Billiar TR, Mazuski JE, Curran RD, Cerra RJ, Simmons RL. Endotoxin modulation of hepatocyte secretory and cellular protein synthesis is mediated by Kupffer cells. Arch Surg 1988;123:1400-5.
23. Billiar TR, Curran RD, Stuehr DJ, West MA, Bentz BG, Simmons RL. An L-arginine-dependent mechanism mediates Kupffer cell inhibition of hepatocyte protein synthesis in vitro. J Exp Med 1989;169:1467-72.
24. Billiar TR, Curran RD, Ferrari FK, Williams DL, Stuehr DJ, Simmons RL. Kupffer cell: hepatocyte cocultures release nitric oxide in response to bacterial endotoxin. J Surg Res 1990;48:349-53.
25. Curran RD, Ferrari FK, Kispert PH, Stadler J, Stuehr DJ, Simmons RL, et al. Nitric oxide and nitric oxide-generating compounds inhibit hepatocyte protein synthesis. FASEB J 1991;5:2085-92.
26. Alexander B. The role of nitric oxide in hepatic metabolism. Nutrition 1998;14:376-90.
27. Thiermermann C, Ruetten H, Wu CC, Vane JR. The multiple organ dysfunction syndrome caused by endotoxin in rat: attenuation of liver dysfunction by inhibitors of nitric oxide. Br J Pharmacol 1995;116:2845-51.
28. Pastor CM, Billiar TR. Nitric oxide causes hyporeactivity to phenylephrine in isolated perfused livers from endotoxin-treated rats. Am J Physiol 1995;268:G177-182.
29. Billiar TR, Curran RD, Stuehr DJ, Hofmann K, Simmons RL, Inhibition of L-arginine metabolism by NG-monomethyl-L-arginine in vivo promotes hepatic damage in response to lipopolysaccharide. In: Moncada S, Higgs EA, eds. Nitric oxide from IL-arginine: a bioregulatory system. Amsterdam: Elsevier, 1990:275-85.
30. Liaudet L, Rosselet A, Schaller MD, Markert M, Perret C, Feihl F. Nonselective versus selective inhibition of inducible nitric oxide synthase in experimental endotoxic shock. J Infect Dis 1998;177: 127-32.
31. Saavedra JE, Billiar TR, Williams DL, Kim YM, Watkins SC, Keefer LK. Targeting nitric oxide (NO) delivery in vivo. Design of a liver-selective NO donor prodrug that blocks tumor necrosis factor-a-induced apoptosis and toxicity in the liver. J Med Chem 1997;40:1947-54.
32. Ou J, Carlos TM, Watkins SC, Saavedra JE, Keefer LK, Kim YM, et al. Differential effects of nonselective nitric oxide synthase (NOS) and selective inducible NOS inhibition on hepatic necrosis, apoptosis, ICAM-1 expression, and neutrophil accumulation during endotoxemia. Nitric Oxide 1997;1:404-16.
33. Harbrecht BG, Billiar TR, Stadler J, Demetris AJ, Ochoa JB, Curran RD, et al. Nitric oxide synthesis serves to reduce hepatic damage during acute murine endotoxemia. Crit Care Med 1992;20:1568-74.
34. Harbrecht BG, Stadler J. Demetris AJ, Simmons RL, Billiar TR. Nitric oxide and prostaglandins interact to prevent hepatic damage during murine endotoxemia. Am J Physiol 1994;266:G1004-10.
35. Nishida J, McCursey RS, McDonnel D, Fox ES. Protective role of NO in hepatic microcirculatory dysfunction during endotoxemia. Am J Physiol 1994;267:G1135-41.
36. Vos TA, Gouw ASH, Klock PA, Havinga R, Van Goor H, Huitena S, et al. Differential effects of nitric oxide synthase inhibitors on endotoxin-induced liver damage in rats. Gastroenterology 1997; 113:1323-33.
37. Wang GS, Liu GT. Role of nitric oxide in immunological liver damage in mice. Biochem Parmacol 1995;49:1277-81.
38. Harbrecht BG, Billiar TR, Stadler J, Demetris AJ, Ochoa J, Curran RD, et al. Inhibition of nitric oxide synthesis during endotoxemia promotes intrahepatic thrombosis and an oxygen-mediated hepatic injury. J Leukoc Biol 1992;52:390-94.
39. Rubanyi GM, Ho EH, Cantor EH, Lumma WC, Parker Botelho LH. Cytoprotective function of nitric oxide: inactivation of Superoxide radicals produced by human leukocytes. Biochem Biophys Res Commun 1991;181:1392-7.
40. Bautista AP, Spitzer JJ. Inhibition of nitric oxide formation in vivo enhances Superoxide release by the perfused liver. Am J Physiol 1994;266:G783-8.
41. Halliwell B, Gutteridge JMC. The importance of free radicals and catalytic metal ions in human diseases. Mol Aspects Med 1985;8:89-193.
42. Kuo PC, Abe KY, Schroeder RA. Oxidative stress increases hepatocytes iNOS gene transcription and promoter activity. Biochem Biophys Res Commun 1997;234:289-92.
43. Kuo PC, Abe KY. Interleukin 1-induced production of nitric oxide inhibits benzenetriol-mediated oxidative injury in rat hepatocytes. Gastroenterology 1995;109:206-16.
44. Taylor BS, Kim YM, Wang Q, Shapiro RA, Billiar TR, Geller DA. Nitric oxide down-regulates hepatocyte-inducible nitric oxide synthase gene expression. Arch Surg 1997;132:1177-83.
45. Liu P, Yin K, Nagele R, Wong PYK. Inhibition of nitric oxide synthase attenuates peroxynitrite generation, but augments neutrophil accumulation in hepatic ischemia-reperfusion in rats. J Pharmacol Exp Ther 1998;284:1139-46.
46. Petros A, Bennet D, Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet 1991;338:1557-8.
47. Kharitonov VG, Sundquist AR, Sharma VS. Kinetics of nitrosation of thiols by nitric oxide in the presence of oxygen. J Biol Chem 1995;270:28158-64.
48. Miles AM, Bohle DS, Glassbrenner PA, Hansert B, Wink DA, Grisham MB. Modulation of superoxide-dependent oxidation and hydroxylation reactions by nitric oxide. J Biol Chem 1996;271: 40-7.
49. Vega VL, Maldonado M, Mardones L, Manriquez V, Vivaldi E, Roa J, et al. Inhibition of nitric oxide synthesis aggravates hepatic oxidative stress and enhanced superoxide dismutase inactivation in rats subjected to tourniquet shock. Shock 1998;9:320-8.
50. Fukahori M, Ichimori KI, Ishida H, Nakawa H, Okino H. Nitric oxide reversibly suppresses xanthine oxidase activity. Free Radical Res 1994;21:203-12.
51. Bedossa P. La matrice extracellulaire hépatique: structure et régulation. Gastroenterol Clin Biol 1994;18:556-67.
52. Friedman SL. The cellular basis of hepatic fibrosis. Mechanisms and treatment strategies. N Engl J Med 1993;328:1828-35.
53. Casini A, Ceni E, Salzano R, Biondi P, Parola M, Galli A, et al. Neutrophil-derived superoxide anion induces lipid peroxydation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. Hepatology 1997;25:361-7.
54. Mourelle M, Muriel P, Favari L, Franco T. Prevention of CC14-induced liver cirrhosis by silymarin. Fundam Clin Pharmacol 1989;3:183-91.
55. Parola M, Muraca R, Dianzani I, Barrera G, Leonarduzzi G, Bendinelli P, et al. Vitamin E dietary supplementation inhibits transforming growth factor b1 gene expression in the rat liver. FEBS Lett 1992;308:267-70.
56. Bedossa P, Houglum K, Trautwein C, Holstege A, Chojkier M. Stimulation of collagen alpha (I) gene expression is associated with lipid peroxidation in hepatocellular injury: a link to tissue tibrosis. Hepatology 1994;19:1262-71.
57. Montosi G, Garuti C, Iannone A, Pietrangelo A. Spatial and temporal dynamics of hepatic stellate cell activation during oxidant-stress-induced fibrogenesis. Am J Pathol 1998;152:1319-26.
58. Lieber CS. Alcohol and the liver: 1994 update. Gastroenterology 1994;106:1085-1105.
59. Kaminura S, Gaal K, Britton RS, Bacon BR, Triadafilopoulos G, Tsukamoto H. Increased 4-hydroxynonenal levels in experimental alcoholic liver disease: association of lipid peroxydation with liver fibrogenesis. Hepatology 1992;16:448-53.
60. Ahotupa M, Béréziat JC, Bussacchini-Griot V, Camus AM, Bartsch H. Lipid peroxidation induced by N-nitrosodimethylamine (NDMA) in rats in vivo and in isolated hepatocytes. Free Rad Res Commun 1987;3:285-91.
61. Singh S, Shackleton G, Ah-Singh E, Chakraborty J, Bailey ME. Antioxydant defenses in the bile duct-ligated rat. Gastroenterology 1992;103:1625-9.
62. Krahenbuhl S, Talos C, Lauterburg BH, Reichen J. Reduced antioxidative capacity in the liver mitochondria from bile duct ligated rats. Hepatology 1995;22:607-12.
63. Pratico D, luliano L, Basili S, Ferro D, Camastra C, Cordova C, et al. Enhanced lipid peroxidation in hepatic cirrhosis. J Invest Med 1998;46:51-7.
64. Pietrangelo A. Metals, oxidative stress, and hepatic fibrogenesis. Semin Liver Dis 1996;13:13-30.
65. Svegliati-Baroni G, de Jager-Frikken, Saccomanno S, Jansen PLM, Jezequel AM, Moshage H. Generation of reactive oxygen species and NO in the early phase of fibrosis: effetcs of interferon-γ (abstract). J Hepatol 1998;28(Suppl 1):83.
66. Ramadori G, Veit T, Schwogler S, Dienes HP, Knittel T, Rieder H, et al. Expression of the gene of the alpha-smooth muscle-actin isoform in rat liver and in rat fat-storing (Ito) cells. Virchows Arch B Cell Pathol Incl Mol Pathol 1990;59:349-357.
67. Rockey DC, Chung JJ. Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility. J Clin Invest 1995;95:1199-206.
68. Kawada N, Kuroki T, Uoya M, Inoue M, Kobayashi K. Smooth muscle α-actin expression in rat hepatic stellate cell is regulated by nitric oxide and cGMP production. Biochem Biophys Res Commun 1996;229:238-42.
69. Rockey DC, Maher J, Jarnagin W, Gabbiani G, Friedman SL. Inhibition of rat hepatic lipocyte activation in culture by interferon y. Hepatology 1992;16:776-84.
70. Beljaars E, Vos TA, Poelstra K, Molema G, Jansen PLM, Meijer DKF, et al. Involvement of NO in the development of liver fibrosis (abstract). Hepatology 1996;24:461A.
71. Bruck R, Shirin H, Aeed H, Zaidel L, Avni Y. Different roles of free hydroxyl radicals, nitric oxide and tumor necrosis factor a in thioacetamide induced liver cirrhosis in rats (abstract). Hepatology 1998;27:A1217.
72. 2b on biliary cirrhosis in the rat are mediated by nitric oxide (abstract). Hepatology 1998;28:301A
73. Vodovotz Y, Bogdan C, Xie QW, Nathan C. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J Exp Med 1993;178:605-13.
74. Jun CD, Choi BM, Kim SU, Lee SY, Kim HM, Chung HT. Down-regulation of transforming growth factor-beta gene expression by antisense oligodeoxynucleotides increases recombinant interferon-gamma-induced nitric oxide synthesis in murine peritoneal macrophages. Immunology 1995;85:114-9.
75. Yoshizumi M, Perrella MA, Burnett JC Jr, Lee ME. Tumor necrosis factor downregulates an endothelial nitric oxide synthase mRNA by shortening its half-life. Circ Res 1993;73:205-209.
76. Sogni P, Moreau R, Lebrec D. Monoxyde d'azote, vasodilatation et cirrhose: un double (dés)équilibre. Gastroenterol Clin Biol 1999;23:101-4.
77. Marteau P, Ballet F, Chazouillères O, Chrétien Y, Rey C, Petit D, et al. Effect of vasodilatators on hepatic microcirculation in cirrhosis: a study in the isolated perfused rat liver. Hepatology 1989;9:820-3.
78. Zhang JX, Bauer M, Clemens MG. Vessel- and target cell-specific actions of endothelin-1 and endothelin-3 in rat liver. Am J Physiol 1995;269:0269-77.
79. Kawada N, Tran Thi TA, Klein H, Decker K. The contraction of hepatic stellate (Ito) cells stimulated with vasoactive substances. Possible involvement of endothelin 1 and nitric oxide in the regulation of the sinusoidal tonus. Eur J Biochem 1993;213:815-23.
80. Zhang B, Borderie D, Sogni P, Soubrane O, Houssin D, Calmus Y. NO-mediated vasodilatation in the rat liver. Role of hepatocytes and liver endothelial cells. J Hepatol 1997;26:1348-55
81. Mittal MK, Gupta TK, Lee FY, Sieber CC, Groszmann RJ. Nitric oxide modulates hepatic vascular tone in normal rat liver. Am J Physiol 1994;267:G416-22.
82. Bauer C, Walcher F, Kalweit U, Larsen R, Marzi I. Role of nitric oxide in the regulation of the hepatic microcirculation in vivo. S Hepatol 1997;27:1089-95.
83. Shah V, Haddad FG, Garcia-Cardena G, Frangos JA, Mennone A, Groszmann RJ, et al. Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J Clin Invest 1997;100:2923-30.
84. Rodés J. The evolution of knowledge on the physiopathology of portal hypertension. In: De Franchis eds. Portal hypertension II 1996;18-29.
85. Lopez-Talavera JC, Martinez M, Genesca J, Gonzales A, Esteban R, Guardia J. Effect of chronic oral L-arginine treatment during the experimental induction of cirrhosis in the systemic and portal hemodynamics of cirrhotic rats (abstract). Hepatology 1996;24: 315A.
86. Gupta TK, Groszmann RJ. Administration of L-arginine, the physiological precursor of nitric oxide, reduces portal perfusion pressure and ameliorates hepatic vascular hyperreactivity in experimental cirrhosis (abstract). Hepatology 1994;20:200A.
87. Van De Casteele M, Reichen J. Hepatic NO synthase is decreased in cirrhotic rats and correlates with hepatic functional impairment (abstract). Hepatology 1997;26:280A.
88. Van De Casteele M, Janssens S, Roskams T, Desmet V, Nevens F, Fevery J. In vivo gene transfer of NO synthase reduces portal pressure in experimental cirrhosis in rats (abstract). Hepatology 1996;24:313A.
89. Omasta AK, Janssens SP, Roskams T, Van De Casteele M, Van Roey G, Nevens F, et al. Gene transfer of ceNOS induces long-term control of portal hypertension in CC14 cirrhotic rats (abstract). Hepatology 1998;27:A1317.
90. Zimmermann H, Kurzen P, Klossner W, Renner EL, Marti U. Decreased constitutive hepatic nitric oxide synthase expression in secondary biliary fibrosis and its changes after Roux-en Y choledocho-jejunostomy in the rat. J Hepatol 1996;25:567-73.
91. Roskams T, Van De Casteele M, Nevens F, Fevery J, Desmet V. Different expression of NO synthase in human cirrhotic liver specimens may be related to different mechanisms of portal hypertension (abstract). Hepatology 1996;24:314 A.
92. Gupta TK, Toruner M, Chung MK, Groszmann RJ. Endothelial dysfunction and decreased production of nitric oxide in the intrahepatic microcirculation of cirrhotic rats. Hepatology 1998; 28:926-31.
93. Shah V, Cadelina G, Sessa WC, Groszmann RJ. Impaired NOS activity associated with enhanced caveolin-1 binding to eNOS in experimental liver cirrhosis (abstract). Hepatology 1998;28:510A.
94. Beljaars E, Vos T, Poelstra K, Molema G, Jansen PLM, Meïjer DKF, et al. Expression of iNOS during development of liver fibrosis in rats. 8th International Symposium on Cells of the Hepatic Sinusoid, Bordeaux: 1996, p 14.
95. Kanwar S, Kubes P, Tepperman BL, Lee SS. Nitric oxide synthase activity in portal-hypertensive and cirrhotic rats. J Hepatol 1996;25;85-9.
96. Sogni P, Moreau R, Gadano A, Lebrec D. The role of nitric oxide in the hyperdynamic circulatory' syndrome associated with portal hypertension. J Hepatol 1995;23:218-24.
97. Cohen JJ. Apoptosis. Immunol Today 1993;14:126-30.
98. Ellis R, Yan JY, Horvitz HR. Mechanisms and functions of cell death. Annu Rev Cell Biol 1991;7:663-98.
99. Steller H. Mechanisms and genes of cellular suicide. Science 1995;267:1445-9.
100. Dimmeler S, Zeiher AM. Nitric oxide and apoptosis: another paradigm for the double-edged role of nitric oxide. Nitric oxide 1997;1:275-81.
101. Fehsel K, Kroncke KD, Meyer KL, Hubert H, Wahn V, Kolb-Bachofen V. Nitric oxide induces apoptosis in mouse thymocytes. J Immunol 1995;155:2858-65.
102. Gerano AM, Hortelano S, Alvarez A, Martinez C, Bosca L. Splenic B lymphocyte programmed cell death is prevented by nitric oxide release through mechanisms involving sustained Bcl-2 levels. J Clin Invest 1995;95:1884-90.
103. Mannick JB, Asano K, Izumi K, Kieff E, Stamler JS. Nitric oxide produced by human B lymphocytes inhibits apoptosis and Epstein-Barr virus reactivation. Cell 1994;79:1137-46.
104. Kim YM, de Vera ME, Watkins SC, Billiar TR. Nitric oxide protects cultured rat hepatocytes from TNFα-induced apoptosis by inducing heat shock protein 70 expression. J Biol Chem 1997;272:1402-11.
105. Kim YM, Talanian RV, Billiar TR. Nitric oxide prevents apoptosis by preventing increases in caspase-3-like activity via two distinct mechanisms. J Biol Chem 1997;272:31138-48.
106. Desmorat H, Vinel JP, Lahlou O, Pipy B, Calès P, et al. Systemic and splanchnic hemodynamic effects of moAsidomine in rats with carbon tetrachloride-induced cirrhosis. Hepatology 1991;13: 1181-4.
107. Fevery J, Roskams T, Van de Casteele M, Omasta A, Janssens S, Desmet V, Nevens F. NO synthase in the liver: prospects of in vivo gene transfer. Digestion 1998;59(supp2):58-9.